D. M. Gleason
机构：Cross Cancer Institute
发表论文 2 篇 · 总被引 1215 次 · h-index 1
代表论文
- Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Metastatic Hormone-Refractory Prostate Cancer (2004 · JNCI Journal of the National Cancer Institute · 被引 1215)
- Clinical benefit of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer based on history of skeletal complications (2004 · Journal of Clinical Oncology)